February 2, 2018 7:41am
Sector intelligence and perspective
The iShares Nasdaq Biotechnology (IBB) is indicating a NEGATIVE -0.11% as is the SPDR S&P Biotech ETF (XBI) is indicating a NEGATIVE -0.38%; the iShares Russell 2000 (IWM) is indicating a NEGATIVE -0.75% while the Health Care Select Sector SPDR ETF (XLV) is NOT indicating in Friday’s pre-open
Keeping an eye on indexes, fundamentals and many of those “other” indicators is an attempt of futility many days to prognosticate sentiment
However, the real issue is that algorithms have become unshackled and I believe contribute to conflicts in sector pricing
Their vulnerability is the “human” that could interrupt their machine learning
Pre-open indications: 4 SELLs and 2 BUYs
Out and about: Athersys (ATHX) has increased its current debt facility. Under the new agreement, ATHX has the right to sell up to $100 million of its common stock to Aspire Capital under certain conditions over a three-year period.
Members only. Please login.